ANAPTYSBIO, INC Annual Income Tax Expense (Benefit) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Anaptysbio, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2023.
  • Anaptysbio, Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Anaptysbio, Inc annual Income Tax Expense (Benefit) for 2023 was -$4K, a 117% decline from 2022.
  • Anaptysbio, Inc annual Income Tax Expense (Benefit) for 2022 was $24K.
  • Anaptysbio, Inc annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4K -$28K -117% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $24K +$24K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2024-03-11
2020 $0 +$152K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$152K +$40K +20.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
2018 -$192K -$192K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $0 -$139K -100% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $139K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.